The link between Janumet (sitagliptin / metformin) and pancreatic cancer is still inconclusive, but patients with a history of type-2 diabetes, Janumet, and symptoms of pancreatic cancer should be evaluated for a potential Janumet pancreatic cancer diagnosis. A diagnosis can usually be made based on blood tests, a CT scan, and a biopsy (tissue sample) taken from the pancreas. If you or your family member was recently diagnosed with pancreatic cancer and you believe Janumet is responsible, you may qualify for compensation by filing a Janumet lawsuit.
What You Can Do & How a Janumet Lawsuit Can Help
The Schmidt Firm, PLLC is currently accepting Janumet induced injury cases in all 50 states. If you or somebody you know was injured by Janumet pancreatic cancer, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.
Janumet Pancreatic Cancer Diagnosis and Tests
A possible risk of pancreatic cancer has been identified in people who use Janumet to control type-2 diabetes. A doctor might suspect a Janumet pancreatic cancer diagnosis in patients who have symptoms, including:
- Abdominal pain, which may radiate to the back
- Nausea
- Vomiting
- Weight loss (unintentional)
- Jaundice
Unfortunately, it is uncommon for an early Janumet pancreatic cancer diagnosis to occur — less than half of people are diagnosed before the cancer metastasizes (spread to distant tissues and/or organs). One reason is because the pancreas is located deep in the abdomen, behind the stomach and above the intestines, where the cancer is unlikely to produce symptoms or be detected by routine medical tests.
How is Janumet Pancreatic Cancer Diagnosed?
Janumet pancreatic cancer diagnosis is usually made based on the patient’s medical history, physical examination, symptoms, and the following tests:
- Computed tomography (CT) scan: This non-invasive imaging tests compiles a set of X-ray images into a 3D picture of the abdomen. It is one of the most useful tests for diagnosis and staging.
- Biopsy: Obtaining a tissue sample (biopsy) from the pancreas is difficult due to its location deep in the abdomen, but minimally-invasive fine-needle aspiration techniques have been developed. A conclusive Janumet pancreatic cancer diagnosis requires a biopsy, which is examined by a pathologist for cancer cells.
Less common Janumet pancreatic cancer tests include:
- Blood tests: Once pancreatic cancer metastasizes, a blood test can identify bio-markers from the tumor. However, it is not useful as an early diagnostic test.
- Ultrasound
- Endoscopic ultrasound
- Magnetic resonance imaging (MRI)
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Laparoscopic surgery
The American Academy of Family Physicians has provided this resource regarding potential Janumet pancreatic cancer diagnosis and management.
Do I have a Janumet Lawsuit?
The Schmidt Firm, PLLC is currently accepting Janumet induced injury cases in all 50 states. If you or somebody you know was injured by Janumet pancreatic cancer, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.
The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs' law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm's reputation for providing personal attention to each and every client we represent.
